Literature DB >> 415097

Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

R Gold, I Goldschneider, M L Lepow, T F Draper, M Randolph.   

Abstract

Asymptomatic carriage of Neisseria meningitidis and Neisseria lactamica was studied in a total of 2,969 healthy infants and children in Danbury, Conn., between October 1971 and June 1975. The prevalence of N. meningitidis averaged 0.71% during the first four years of life and increased to 5.4% by 14--17 years. Rates of carriage of N. lactamica increased from 3.8% in three-month-old infants to a peak of 21.0% at 18 months and then declined to 1.8% by 14--17 years of age. Of the children who acquired N. lactamica, 66% developed fourfold or greater rises in titers of IgG antibody to groups A, B, and/or C meningococci as determined by immunofluorescence compared with only 5% of control children. Of new carriers of N. lactamica, 40% developed increased titers of bactericidal antibody to groups A, B, and/or C meningococci as compared with 7% of noncarriers. Carriage of N. lactamica may assist in the development of natural immunity to N. meningitidis by induction of cross-reactive antibodies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 415097     DOI: 10.1093/infdis/137.2.112

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  106 in total

1.  Meningococcal disease in healthcare workers. Vaccine is available in Latin America.

Authors:  C Trujillo
Journal:  BMJ       Date:  2000-01-22

2.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

3.  Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination.

Authors:  D A Ala'Aldeen; K R Neal; K Ait-Tahar; J S Nguyen-Van-Tam; A English; T J Falla; P M Hawkey; R C Slack
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 4.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.

Authors:  Ray Borrow; Ingeborg S Aaberge; George F Santos; T Lynn Eudey; Philipp Oster; Anne Glennie; Jamie Findlow; E Arne Høiby; Einar Rosenqvist; Paul Balmer; Diana Martin
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

6.  Effectiveness of different policies in preventing meningococcal disease clusters following a single case in day-care and pre-school settings in Europe.

Authors:  D Boccia; N Andrews; S Samuelsson; S Heuberger; A Perrocheau; J M Stuart
Journal:  Epidemiol Infect       Date:  2006-01-18       Impact factor: 2.451

7.  Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterization.

Authors:  Paul A Kristiansen; Fabien Diomandé; Rasmata Ouédraogo; Idrissa Sanou; Lassana Sangaré; Abdoul-Salam Ouédraogo; Absatou Ky Ba; Denis Kandolo; Jennifer Dolan Thomas; Thomas A Clark; Marie-Pierre Préziosi; F Marc Laforce; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Neisseria infection of rhesus macaques as a model to study colonization, transmission, persistence, and horizontal gene transfer.

Authors:  Nathan J Weyand; Anne M Wertheimer; Theodore R Hobbs; Jennifer L Sisko; Nyiawung A Taku; Lindsay D Gregston; Susan Clary; Dustin L Higashi; Nicolas Biais; Lewis M Brown; Shannon L Planer; Alfred W Legasse; Michael K Axthelm; Scott W Wong; Magdalene So
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Infection with an avirulent phoP mutant of Neisseria meningitidis confers broad cross-reactive immunity.

Authors:  J Newcombe; L-J Eales-Reynolds; L Wootton; A R Gorringe; S G P Funnell; S C Taylor; J J McFadden
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 10.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.